Similarly, administration of antagonists at mGlu5R, which attenuates dyskinesia in experimental PD, is associated with reduced striatal levels of phosphorylated ERK and MSK1 (Rylander et al. 2009). This evidence concerns the gene RPS6KA5 and Dyskinesia.